查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球多模态成像市场：按技术、按用途、按最终用户、按地区 - 预测至 2028 年
市场调查报告书
商品编码
1345520

全球多模态成像市场：按技术、按用途、按最终用户、按地区 - 预测至 2028 年

Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT/FMT), Application (Oncology, Cardiology, Brain, Ophthalmology), End User (Hospitals, Diagnostic Centers, Academia, Research) & Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 213 Pages | 订单完成后即时交付

价格
简介目录

全球多模态成像市场规模预计将从2023年的42亿美元增至2028年的55亿美元，2023年至2028年的年复合成长率为5.7%。

目标疾病的高罹患率/患病率、影像中心/程序数量的增加、对疾病早期诊断益处的认识不断增强、技术先进的影像系统、能力和模式的快速采用这些要素要素了该市场的不断增长。

从技术来看，多模态成像市场由PET-CT细分市场主导，占据了市场的主要份额。在一次会话中进行 PET 和 CT 扫描可减少辐射暴露和扫描时间，其临床多功能性扩展到肿瘤学、心脏病学、神经学和感染疾病学。儘管初始成本较高，但 PET-CT 的成本效益来自于诊断的改进、对其他检查的需求的减少以及研究的进步，使其成为一种有价值的工具，对患者的治疗结果和医学研究具有显着的好处，并正在推动医疗保健的增长。该产品部分。

在多模态成像市场中，肿瘤学在 2022 年占据最大的市场份额。该细分市场所占的较大份额是由于该系统的用途、图像质量、先进功能和易用性，以及其在医院和医疗机构的急症护理和紧急护理中的使用不断增加。

从最终用户来看，到 2022 年，诊断成像中心行业将在多模态成像市场中占据最大份额。通过整合PET-CT、MRI-PET 和 SPECT-CT 等多种成像模式，诊断成像中心可以提供更准确、更可靠的诊断，从而製定更好的治疗计划并改善患者的治疗结果。此外，多模态成像的用途使这些中心能够容纳广泛的医学专业，并有效地服务于具有不同医疗保健需求的患者。

本报告调查了全球数字孪生市场，用途、行业、公司、地区以及进入市场的公司概况总结了趋势。

目录

第1章简介

第2章调查方法

第3章执行摘要

第4章重要考察

第5章市场概况

  • 介绍
  • 市场动态
  • 波特五力分析
  • 法规趋势
  • 法规分析
  • 赎回场景
  • 生态系统绘图
  • 价值链分析
  • 供应链分析
  • 专利分析
  • 贸易分析
  • 重大会议及活动
  • 技术分析
  • 案例研究分析
  • 价格分析

第6章按技术分類的多模态成像市场

  • 介绍
  • PET/CT系统
  • SPEC/CT系统
  • PET/MR系统
  • OCT/FMT系统
  • 其他的

第7章多模态成像市场（按用途）

  • 介绍
  • 肿瘤学
  • 心脏病
  • 眼科
  • 大脑/神经
  • 研究
  • 其他的

第8章多模态成像市场（按最终用户）

  • 介绍
  • 医院
  • 影像诊断中心
  • 学术研究所
  • 其他的

第9章多模态成像市场（按地区）

  • 介绍
  • 北美
  • 欧洲
  • 亚太地区
  • 拉美
  • 中东/非洲

第10章竞争形势

  • 概述
  • 主要参与企业采取的策略
  • 收入份额分析
  • 市场份额分析
  • 主要企业企业评价矩阵（2022年）
  • 初创企业/中小企业的企业评估矩阵（2022）
  • 竞争标杆管理
  • 竞争格局及趋势

第11章公司简介

  • 主要参与企业
    • GE HEALTHCARE
    • KONINKLIJKE PHILIPS NV
    • CANON MEDICAL SYSTEMS CORPORATION
    • SIEMENS HEALTHINEERS
    • ZEISS GROUP
    • BRUKER
    • MEDISO LTD.
    • NEUSOFT CORPORATION.
    • INFRAREDX, INC.（PART OF NIPRO CORPORATION）
    • TOPCON CORPORATION
    • SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
    • HEIDELBERG ENGINEERING
    • SPECTRUM DYNAMICS MEDICAL
    • MINFOUND MEDICAL SYSTEMS CO., LTD.
    • KINDSWAY BIOTECH
  • 其他公司
    • SOFIE BIOSCIENCES, INC.
    • REFLEXION MEDICAL, INC.
    • CUBRESA INC.
    • FUJIFILM CORPORATION
    • POSITRON
    • MR SOLUTIONS
    • ALCON INC.
    • ESSILOR INSTRUMENTS USA
    • NIDEK CO., LTD.
    • ZIEMER OPHTHALMIC SYSTEMS AG

第12章附录

简介目录
Product Code: MD 7353

The global multimodal market is projected to reach USD 5.5 billion by 2028 from USD 4.2 billion in 2023, at a CAGR of 5.7% from 2023 to 2028. Factors such as the high incidence/prevalence of target diseases, the growing number of diagnostic imaging centers/procedures, increasing awareness about the benefits of early diagnosis of diseases, and the rapid adoption of technologically advanced imaging systems, features and modalities are responsible for the increasing growth of this market.

"The PET-CT segment of technology segment l held the largest share of the market in 2022"

Based on technology, the multimodal market is segmented into PET-CT, PET/MR, SPECT-CT, OCT/FMT and other multimodal imaging . The PET-CT segment held a major share of the market. Conducting PET and CT scans in a single session reduces radiation exposure and scan time, while its clinical versatility spans oncology, cardiology, neurology, and infectious diseases. Despite initial costs, the cost-effectiveness of PET-CT emerges from improved diagnostics, reduced need for additional tests, and research advancements, making it a valuable tool that significantly benefits patient outcomes and medical research are driving the growth of this product segment.

"The oncology segment is projected to register the highest CAGR during the forecast period"

Based on application, the multimodal market is segmented into brain & neurology, cardiology, oncology, ophthalmology, research and other applications. The oncology segment accounted for the largest market share in 2022. The large share of this segment is attributed to the system's versatility, image quality, ehanced, easy to use features, and due to the increased usage of it in acute care settings and emergency care in hospitals and healthcare institutions.

"The diagnostic imaging centers segment for end user segment is projected to register a significant CAGR during the forecast period"

On the basis of end user, the multimodal market is segmented into hospitals, diagnostic imaging cneters, academic and research institutes. The diagnostic imaging centers segment accounted for the largest share of the multimodal market in 2022. By integrating multiple imaging modalities, such as PET-CT, MRI-PET, or SPECT-CT, diagnostic imaging centers can provide more accurate and reliable diagnoses, leading to better treatment planning and improved patient outcomes. Moreover, the versatility of multimodal imaging enables these centers to cater to a wide range of medical specialties, effectively serving patients with diverse healthcare needs.

"The market in the North America region is expected to witness the highest growth during the forecast period."

The multimodal market in the North America region is expected to register a CAGR during the forecast period, primarily due to the high healthcare spending in the region, rising prevalence of target diseases, increasing research activities, growing number of cosmetic surgeries, and technological advancements in imaging systems.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: Director-level-14%, C-level-10%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

The prominent players in the multimodal market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Neusoft (China), Topcon Corporation (Japan), and Bruker (US) among others.

Research Coverage

This report studies the multimodal market based on technology, display, portability, component, application, enduser, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall multimodal market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (rising target patient population, growing adoption of multimodal imaging devices, technological advancement, and increasing investment, funds, and grants by public-private organizations), restraints (high capital and operational cost, unfavorable regulatory guidelines), opportunities (improving healthcare infrastructure across emerging countries, PET utilization for breast imaging, promising product pipeline), and challenges (availability of alternate imaging technologies) influencing the growth of the multimodal market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the multimodal market
  • Market Development: Comprehensive information about lucrative markets-the report analyses the multimodal market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the multimodal market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Neusoft (China), Topcon Corporation (Japan), and Bruker (US) among others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 GEOGRAPHICAL SEGMENTATION
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY
  • 1.6 RESEARCH LIMITATIONS
  • 1.7 STAKEHOLDERS
  • 1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 MULTIMODAL IMAGING MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primaries
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 5 MARKET SIZE ESTIMATION FOR MULTIMODAL IMAGING: APPROACH 1 (COMPANY REVENUE ESTIMATION)
    • FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF SIEMENS HEALTHINEERS
      • 2.2.1.2 Approach 2: Customer-based market estimation
      • 2.2.1.3 Multimodal imaging market: Top-down approach
      • 2.2.1.4 Approach 3: CAGR projections
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ASSESSMENT
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 GROWTH RATE ASSUMPTIONS
  • 2.7 RISK ASSESSMENT
    • 2.7.1 MULTIMODAL IMAGING MARKET: RISK ASSESSMENT
  • 2.8 RECESSION IMPACT

3 EXECUTIVE SUMMARY

    • FIGURE 9 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 MULTIMODAL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 MULTIMODAL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 GEOGRAPHICAL SNAPSHOT OF MULTIMODAL IMAGING MARKET

4 PREMIUM INSIGHTS

  • 4.1 MULTIMODAL IMAGING MARKET OVERVIEW
    • FIGURE 13 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE MARKET
  • 4.2 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 PET/CT MULTIMODAL IMAGING SYSTEMS TO DOMINATE NORTH AMERICAN MARKET IN 2023
  • 4.3 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 HOSPITALS TO DOMINATE ASIA PACIFIC MARKET IN 2023
  • 4.4 EUROPE: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 ONCOLOGY SEGMENT TO DOMINATE EUROPEAN MARKET DURING FORECAST PERIOD
  • 4.5 MULTIMODAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 MULTIMODAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing applications of multimodal imaging systems
      • 5.2.1.2 Technological advancements in diagnostic imaging modalities
    • TABLE 1 TECHNOLOGICAL ADVANCEMENTS IN MULTIMODAL IMAGING SYSTEMS
      • 5.2.1.3 Availability of funding for research
      • 5.2.1.4 Increasing establishment of hospitals and diagnostic imaging centers
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable healthcare reforms
      • 5.2.2.2 High capital and operational cost
      • 5.2.2.3 Lack of adequate healthcare infrastructure
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Availability of reimbursement and insurance coverage for scans
    • TABLE 2 CODES FOR SPECT/CT FUSION IMAGING (AS OF 2021)
    • TABLE 3 NATIONAL PET, PET/CT COVERAGE FOR ONCOLOGY (AS OF 2021)
      • 5.2.3.2 Increasing R&D into radiotracers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Growing end-user preference for refurbished equipment
      • 5.2.4.2 Dearth of trained professionals
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 MULTIMODAL IMAGING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 REGULATORY TRENDS
    • 5.4.1 REGULATORY TRENDS FOR MULTIMODAL IMAGING MARKET
  • 5.5 REGULATORY ANALYSIS
    • 5.5.1 NORTH AMERICA
      • 5.5.1.1 US
    • TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.5.1.2 Canada
    • TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.5.2 EUROPE
    • 5.5.3 ASIA PACIFIC
      • 5.5.3.1 Japan
    • TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.5.3.2 China
    • TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.5.3.3 India
  • 5.6 REIMBURSEMENT SCENARIO
    • TABLE 10 MEDICAL REIMBURSEMENT CPT CODES FOR MULTIMODAL IMAGING PROCEDURES IN US (AS OF 2021)
  • 5.7 ECOSYSTEM MAPPING
  • 5.8 VALUE CHAIN ANALYSIS
    • 5.8.1 RESEARCH & PRODUCT DEVELOPMENT
    • 5.8.2 RAW MATERIAL AND MANUFACTURING
    • 5.8.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES
    • FIGURE 19 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
  • 5.9 SUPPLY CHAIN ANALYSIS
    • 5.9.1 PROMINENT COMPANIES
    • 5.9.2 SMALL AND MEDIUM-SIZED ENTERPRISES
    • 5.9.3 END USERS
    • TABLE 11 MULTIMODAL IMAGING MARKET: SUPPLY CHAIN ECOSYSTEM
    • FIGURE 20 MULTIMODAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS
  • 5.10 PATENT ANALYSIS
    • FIGURE 21 PATENTS FOR PET/CT IMAGING SYSTEMS (JANUARY 2013-JULY 2023)
    • FIGURE 22 PATENTS FOR PET/MR IMAGING SYSTEMS (JANUARY 2013-JULY 2023)
    • FIGURE 23 PATENTS FOR SPECT/CT IMAGING SYSTEMS (JANUARY 2013-JULY 2023)
    • FIGURE 24 PATENTS FOR OCT IMAGING SYSTEMS (JANUARY 2013-JULY 2023)
  • 5.11 TRADE ANALYSIS
    • 5.11.1 MULTIMODAL IMAGING MARKET: TRADE ANALYSIS
    • TABLE 12 IMPORT DATA FOR MULTIMODAL IMAGING (HS CODE 901820), BY COUNTRY, 2018-2022 (USD)
    • TABLE 13 EXPORT DATA FOR MULTIMODAL IMAGING (HS CODE 901820), BY COUNTRY, 2018-2022 (USD)
  • 5.12 KEY CONFERENCES AND EVENTS
    • TABLE 14 MULTIMODAL IMAGING MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023-2025)
  • 5.13 TECHNOLOGY ANALYSIS
  • 5.14 CASE STUDY ANALYSIS
    • TABLE 15 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
    • TABLE 16 CASE STUDY 2: PROVIDING COMPREHENSIVE TRAINING PROGRAMS FOR EVOLVING MULTIMODAL IMAGING TECHNIQUES
  • 5.15 PRICING ANALYSIS
    • TABLE 17 REGION-WISE PRICE RANGE FOR MULTIMODAL IMAGING SYSTEMS

6 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
    • TABLE 18 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 6.2 PET/CT SYSTEMS
    • 6.2.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
    • TABLE 19 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 20 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 21 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 6.3 SPECT/CT SYSTEMS
    • 6.3.1 INCREASING APPLICATIONS OF SPECT/CT SYSTEMS TO DRIVE MARKET
    • TABLE 22 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 23 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 24 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 6.4 PET/MR SYSTEMS
    • 6.4.1 ADVANTAGES OFFERED OVER PET/CT SYSTEMS FOR DIAGNOSTIC PURPOSES TO PROPEL MARKET
    • TABLE 25 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 26 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 27 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 6.5 OCT/FMT SYSTEMS
    • 6.5.1 INCREASING APPLICATIONS IN RETINAL DISEASE DIAGNOSIS TO DRIVE MARKET
    • TABLE 28 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 29 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 30 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 6.6 OTHER MULTIMODAL IMAGING SYSTEMS
    • TABLE 31 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 32 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 33 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021-2028 (USD MILLION)

7 MULTIMODAL IMAGING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 34 MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 7.2 ONCOLOGY
    • 7.2.1 INCREASING DEMAND FOR EARLY AND ACCURATE CANCER DIAGNOSIS TO DRIVE MARKET
    • TABLE 35 MULTIMODAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 CARDIOLOGY
    • 7.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE GROWTH
    • TABLE 36 MULTIMODAL IMAGING MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 OPHTHALMOLOGY
    • 7.4.1 TECHNOLOGICAL INNOVATIONS IN OPHTHALMIC MULTIMODAL IMAGING SYSTEMS TO SUPPORT MARKET GROWTH
    • TABLE 37 MULTIMODAL IMAGING MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 7.5 BRAIN & NEUROLOGY
    • 7.5.1 INCREASING INCIDENCE OF BRAIN & NEUROLOGICAL DISORDERS TO PROPEL ADOPTION OF MULTIMODAL IMAGING SYSTEMS
    • TABLE 38 MULTIMODAL IMAGING MARKET FOR BRAIN & NEUROLOGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 7.6 RESEARCH
    • 7.6.1 CAPABILITY TO PROVIDE COMPREHENSIVE AND SYNERGISTIC INSIGHTS INTO COMPLEX PHENOMENA TO SUPPORT MARKET GROWTH
    • TABLE 39 MULTIMODAL IMAGING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 7.7 OTHER APPLICATIONS
    • TABLE 40 MULTIMODAL IMAGING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

8 MULTIMODAL IMAGING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 41 MULTIMODAL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 8.2 HOSPITALS
    • 8.2.1 HIGH PROCEDURAL VOLUMES TO ENSURE SUSTAINED DEMAND FOR MULTIMODAL IMAGING
    • TABLE 42 MULTIMODAL IMAGING MARKET FOR HOSPITALS, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 DIAGNOSTIC IMAGING CENTERS
    • 8.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH
    • TABLE 43 MULTIMODAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 8.4 ACADEMIC & RESEARCH INSTITUTES
    • 8.4.1 GROWING AVAILABILITY OF RESEARCH GRANTS AND FUNDING TO DRIVE MARKET
    • TABLE 44 MULTIMODAL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
  • 8.5 OTHER END USERS
    • TABLE 45 MULTIMODAL IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

9 MULTIMODAL IMAGING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 46 MULTIMODAL IMAGING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • 9.2.1 RECESSION IMPACT
    • FIGURE 25 NORTH AMERICA: MULTIMODAL IMAGING MARKET SNAPSHOT
    • TABLE 47 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 50 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.2 US
      • 9.2.2.1 Rising geriatric population to drive market
    • TABLE 51 US: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Government investments to support market growth
    • TABLE 52 CANADA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • 9.3.1 RECESSION IMPACT
    • TABLE 53 EUROPE: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 EUROPE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 55 EUROPE: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 56 EUROPE: MULTIMODAL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Increasing prevalence of chronic diseases to drive market
    • TABLE 57 GERMANY: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Rising number of diagnostic imaging centers to propel market
    • TABLE 58 FRANCE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.3.4 UK
      • 9.3.4.1 Government initiatives to support market growth
    • TABLE 59 UK: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Availability of reimbursement coverage to support market growth
    • TABLE 60 ITALY: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.3.6 SPAIN
      • 9.3.6.1 Increasing public funding for cell-based research to propel market
    • TABLE 61 SPAIN: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • TABLE 62 REST OF EUROPE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • 9.4.1 RECESSION IMPACT
    • FIGURE 26 ASIA PACIFIC: MULTIMODAL IMAGING MARKET SNAPSHOT
    • TABLE 63 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 65 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 66 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Rapidly growing geriatric population to propel market
    • TABLE 67 CHINA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.3 JAPAN
      • 9.4.3.1 High adoption of advanced technologies to support market growth
    • TABLE 68 JAPAN: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Rising prevalence of various chronic diseases to drive market
    • TABLE 69 INDIA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Increasing investments in research to provide opportunities for market growth
    • TABLE 70 AUSTRALIA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Presence of well-developed healthcare system to propel market
    • TABLE 71 SOUTH KOREA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.7 REST OF ASIA PACIFIC
    • TABLE 72 REST OF ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 RECESSION IMPACT
    • TABLE 73 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 75 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 76 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.5.2 BRAZIL
      • 9.5.2.1 Favorable demographic conditions to drive market
    • TABLE 77 BRAZIL: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.5.3 MEXICO
      • 9.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market
    • TABLE 78 MEXICO: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.5.4 REST OF LATIN AMERICA
    • TABLE 79 REST OF LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING MEDICAL TOURISM TO DRIVE MARKET
    • 9.6.2 RECESSION IMPACT
    • TABLE 80 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 81 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 82 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MULTIMODAL IMAGING MARKET
  • 10.3 REVENUE SHARE ANALYSIS
    • FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MULTIMODAL IMAGING MARKET, 2020-2022
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 28 MARKET SHARE ANALYSIS OF TOP PLAYERS IN MULTIMODAL IMAGING MARKET, 2022
    • TABLE 83 MULTIMODAL IMAGING MARKET: DEGREE OF COMPETITION
  • 10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 29 MULTIMODAL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
  • 10.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 30 MULTIMODAL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
  • 10.7 COMPETITIVE BENCHMARKING
    • TABLE 84 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
    • TABLE 85 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES
    • TABLE 86 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
  • 10.8 COMPETITIVE SCENARIO AND TRENDS
    • TABLE 87 PRODUCT LAUNCHES, JANUARY 2020-JULY 2023
    • TABLE 88 DEALS, JANUARY 2020-JULY 2023
    • TABLE 89 OTHER DEVELOPMENTS, JANUARY 2020-JULY 2023

11 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) **
  • 11.1 KEY PLAYERS
    • 11.1.1 GE HEALTHCARE
    • TABLE 90 GE HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 31 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
    • 11.1.2 KONINKLIJKE PHILIPS N.V.
    • TABLE 91 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 11.1.3 CANON MEDICAL SYSTEMS CORPORATION
    • TABLE 92 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
    • FIGURE 33 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.4 SIEMENS HEALTHINEERS
    • TABLE 93 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
    • FIGURE 34 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
    • 11.1.5 ZEISS GROUP
    • TABLE 94 ZEISS GROUP: COMPANY OVERVIEW
    • FIGURE 35 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2022)
    • 11.1.6 BRUKER
    • TABLE 95 BRUKER: COMPANY OVERVIEW
    • FIGURE 36 BRUKER: COMPANY SNAPSHOT (2022)
    • 11.1.7 MEDISO LTD.
    • TABLE 96 MEDISO LTD.: COMPANY OVERVIEW
    • 11.1.8 NEUSOFT CORPORATION.
    • TABLE 97 NEUSOFT CORPORATION: COMPANY OVERVIEW
    • 11.1.9 INFRAREDX, INC. (PART OF NIPRO CORPORATION)
    • TABLE 98 INFRAREDX, INC.: COMPANY OVERVIEW
    • FIGURE 38 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.10 TOPCON CORPORATION
    • TABLE 99 TOPCON CORPORATION: COMPANY OVERVIEW
    • FIGURE 39 TOPCON CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.11 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
    • TABLE 100 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW
    • 11.1.12 HEIDELBERG ENGINEERING
    • TABLE 101 HEIDELBERG ENGINEERING: COMPANY OVERVIEW
    • 11.1.13 SPECTRUM DYNAMICS MEDICAL
    • TABLE 102 SPECTRUM DYNAMICS MEDICAL: COMPANY OVERVIEW
    • 11.1.14 MINFOUND MEDICAL SYSTEMS CO., LTD.
    • TABLE 103 MINFOUND MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW
    • 11.1.15 KINDSWAY BIOTECH
    • TABLE 104 KINDSWAY BIOTECH: COMPANY OVERVIEW
  • 11.2 OTHER COMPANIES
    • 11.2.1 SOFIE BIOSCIENCES, INC.
    • 11.2.2 REFLEXION MEDICAL, INC.
    • 11.2.3 CUBRESA INC.
    • 11.2.4 FUJIFILM CORPORATION
    • 11.2.5 POSITRON
    • 11.2.6 MR SOLUTIONS
    • 11.2.7 ALCON INC.
    • 11.2.8 ESSILOR INSTRUMENTS USA
    • 11.2.9 NIDEK CO., LTD.
    • 11.2.10 ZIEMER OPHTHALMIC SYSTEMS AG
  • *Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS